Tag: AEMD

Blue Horseshoe Stocks: Update on AEMD & More

Aethlon Medical, Inc. AEMD

Yesterday’s standout play was AEMD, a stock that we’ve been tracking since October 14th. Following that initial alert, we observed a low of .20 in AEMD, and after trading sideways for the remainder of last month, the stock has been gaining ground steadily over the past few weeks.

We re-flagged it in yesterday’s extended watchlist and witnessed a 27% intraday run from .562-.717 on approximately 10X the 3-month average trading volume. At its high mark of .717, AEMD was showing us an increase of 258% over the lows we observed barely a month ago.

The event that prompted us to originally begin following AEMD was during the height of the Ebola scare, when the company announced that its “Hemopurifier” blood-cleansing system was to be used to treat an Ebola patient overseas. This morning, we ‘re getting word that the patient (who was experiencing multiple organ failure at the time the treatment was administered) has now been discharged from the hospital. >>> FULL PR

It will be interesting to see the effect this news has on AEMD as we approach the holiday hiatus, which shortens this to a 3½ day trading week.

Petroleo Brasiliero S.A. (Petrobras) PBR -Options

PBR is gapping up again this morning, in the wake of yesterday’s announcement that its ‘Cidade de Ilhabela’ offshore oil platform had been brought online. (Read our comments on the company’s situation in yesterday’s report if you missed it)

Anyone who caught yesterday’s morning report will recall our options-trading targets; we were considering the Jan 17th $10 and $11 Calls. The gap-and-fade that followed provided us a good opportunity to snap up some discounted contracts, and we’ll be looking to lock in some profits on the gap-up we’re seeing this morning.

SinoCoking Coal and Coke Chemical Industries, Inc. SCOK

Another play that we’ve been monitoring for some time is SCOK, which we’ll want to watch closely today on the heels of a notable PR released this morning. According to SCOK, the syngas plant that it recently opened in China is now operating at 100% capacity and pulling more than $80K worth of syngas from the Earth per day.

We actually began tracking SCOK the morning it announced its intent to open the facility, (it ran hard that day from 3.35-9.37, +180%) so this morning’s PR regarding the plant acheiving full operational status brings us full circle with SCOK.

PINGDINGSHAN, China, Nov. 25, 2014 (GLOBE NEWSWIRE) — SinoCoking Coal and Coke Chemical Industries, Inc. (SCOK), a producer of clean energy products located in Henan Province, today announced that its above ground facility for the conversion of carbon dioxide into clean-burning syngas has achieved its initial production target of 25,000 cubic meters per hour and is currently transporting syngas to three customers and agents in and around its facility in Pingdingshan.

Based on the current price of $0.139 per cubic meter for syngas, the gross revenue generated per day by the aboveground facility is approximately $83,280. Gross profit margin is expected to be between 45% and 50%. >> FULL PR

Extended Watchlist:
ISNS, LAKE, CAMT, DRWI, LIVE

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.

Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.

Extended Watchlist:
MOLG, GERN, CIMT, SYN, AEMD, MY

Blue Horseshoe Stocks: A Word on Ebola & Much More

A Word on the “Ebola Effect”

In a hype-filled environment that is beginning to resemble early-2014’s cannabis “green rush”, most stocks with news announcements even remotely connected to the Ebola virus have been seeing exponential spikes in activity. Fear, no matter how irrational, can be one of the market’s most potent driving forces, and we are seeing affirmations of this left and right. Regardless of the cause or rationale, we are always standing at the ready to take advantage of powerful trends, and so far we’ve done a pretty good job of tracking down some Ebola-related winners in the last couple of weeks.. There were two in yesterday’s report alone.

NanoLogix, Inc. NNLX

NNLX was a standout which announced yesterday morning that it was “configuring its N-Assay Rapid diagnostic kits for both Ebola Virus and Enterovirus detection”  and as a result, the stock leaped out of the gate to make a serious move first thing in the morning. It traded in a massive range, running rapidly from .06 to .18;  a full 200% intraday move!

  Aethlon Medical, Inc. AEMD

AEMD was another one we were tracking from yesterday’s newsletter, and the company subsequently published a report stating that it had used its “Hemopurifier” to treat an Ebola patient in Sierra Leone. It led to a 37% intraday swing (.19-26).

New Entry on Our Ebola Watchlist:

We’re also going to radar WholeHealth Products, Inc. GWPC after we caught an after-hours PR yesterday evening. With untraded-upon news on such a hot topic, we’ll be anxious to see how the stock responds today.

Accentia BioPharmaceticals, Inc.  ABPI

While not an Ebola-connected biopharma play, were glad to have included ABPI in yesterday’s premarket report. Its SinuNase sinusitis treatment has been fast-tracked by the FDA, and the company happened to release word that “several unnamed pharmaceutical companies… have approached the company over SinuNase.”

The announcement caused a monstrous spike in early trading with stock jumping up from the open at .0065 and reaching .027! That works out to a mammoth move of 315% and there was also a subsequent dip-and-rip as the stock came off that initial high. It bounced off of a penny and ran back to .023, adding a 130% swing, and that was followed by yet another from .0107 to .018 (+68%).

In total, we witnessed 513% in cumulative gains for the day, so congrats to anyone who caught our tag, because even if you only took advantage of a fraction of those intraday moves, chances are you still walked away with a tidy profit.

ChinaNet Online Holdings, Inc. CNET

We’ve been tracking CNET pretty closely since we first caught it on a momentum scan back on Sept. 22nd, and re-tagged it in yesterday’s report. Following some news, we saw a couple of respectable intraday swings out of the stock. First, from 1.55 to 2.17 (+40%), and then again from 1.83 to 2.16 (+18%).

The company announced it was teaming with credit search engine Haodai and the Yooli crowdfunding outfit to offer “Zero Down Payment Loans” to entrepreneurs. >>View PR

Extended Watchlist:
APT, VSR, PPHM, RCPI, IBIO,